1. Home
  2. AMPS vs PHAR Comparison

AMPS vs PHAR Comparison

Compare AMPS & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPS
  • PHAR
  • Stock Information
  • Founded
  • AMPS 2009
  • PHAR 1988
  • Country
  • AMPS United States
  • PHAR Netherlands
  • Employees
  • AMPS N/A
  • PHAR N/A
  • Industry
  • AMPS Electric Utilities: Central
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMPS Utilities
  • PHAR Health Care
  • Exchange
  • AMPS Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • AMPS 608.0M
  • PHAR 679.0M
  • IPO Year
  • AMPS N/A
  • PHAR N/A
  • Fundamental
  • Price
  • AMPS $3.66
  • PHAR $9.44
  • Analyst Decision
  • AMPS Strong Buy
  • PHAR Strong Buy
  • Analyst Count
  • AMPS 9
  • PHAR 3
  • Target Price
  • AMPS $5.38
  • PHAR $27.00
  • AVG Volume (30 Days)
  • AMPS 1.4M
  • PHAR 6.7K
  • Earning Date
  • AMPS 03-13-2025
  • PHAR 03-13-2025
  • Dividend Yield
  • AMPS N/A
  • PHAR N/A
  • EPS Growth
  • AMPS N/A
  • PHAR N/A
  • EPS
  • AMPS 0.22
  • PHAR N/A
  • Revenue
  • AMPS $185,992,000.00
  • PHAR $285,745,000.00
  • Revenue This Year
  • AMPS $30.56
  • PHAR $20.08
  • Revenue Next Year
  • AMPS $17.93
  • PHAR $9.22
  • P/E Ratio
  • AMPS $15.00
  • PHAR N/A
  • Revenue Growth
  • AMPS 25.90
  • PHAR 30.64
  • 52 Week Low
  • AMPS $2.71
  • PHAR $6.65
  • 52 Week High
  • AMPS $7.28
  • PHAR $13.20
  • Technical
  • Relative Strength Index (RSI)
  • AMPS 35.67
  • PHAR 46.17
  • Support Level
  • AMPS $3.82
  • PHAR $9.37
  • Resistance Level
  • AMPS $4.24
  • PHAR $10.01
  • Average True Range (ATR)
  • AMPS 0.26
  • PHAR 0.50
  • MACD
  • AMPS -0.10
  • PHAR -0.13
  • Stochastic Oscillator
  • AMPS 10.04
  • PHAR 0.00

About AMPS Altus Power Inc.

Altus Power Inc is a developer, owner, and operator of large-scale photovoltaic and energy storage systems across the United States. The company serve commercial, industrial, public sector, and community solar customers. Its mission is to drive the clean energy transition by developing and operating solar generation and energy storage facilities. It owns a diverse portfolio of solar PV systems and has long-term agreements with enterprise entities and residential customers. Their primary product offerings include leases and revenue contracts for solar power generation, alongside electric vehicle charging and energy storage solutions. Revenue streams include power purchase agreements, net metering credit agreements, and SREC revenue.

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

Share on Social Networks: